While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Whilst vaccines exist for animals, none are commercially available for human use for the mosquito-borne virus.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Vaxxas and CEPI advance US$ 4.8 million programme for needle-free thermostable mRNA vaccines: Cambridge, Massachusetts Friday, January 24, 2025, 14:00 Hrs [IST] Vaxxas, a clinical ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.